MRC1 and congenital rubella syndrome: This could be compounded by sub-optimal vaccine coverage increasing the average age at infection [26] and consequently potentially increasing rates of IM – similarly to how sub-optimal coverage of the MMR vaccine led to an increase in congenital rubella syndrome in Greece [27, 28].